Why the study?
Do chimeric spike mRNA vaccines protect against Sarbecovirus challenge in vulnerable aged mice?
Population
Vulnerable aged mice
Comparison
Chimeric spike mRNA vaccines vs SARS-CoV-2 mRNA vaccination
Design
Preclinical animal study
Authors
Loading...
Supports advancement to primate models; leaves open human translation for Sarbecovirus protection.
Do chimeric spike mRNA vaccines protect against Sarbecovirus challenge in vulnerable aged mice?
Multiplexed-chimeric spike mRNA vaccines can prevent SARS-like zoonotic coronavirus infections with pandemic potential in a mouse model.
Martinez et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: